We surveyed U.S. reinsurers regarding their practices and viewpoints
about use of the NT-proBNP cardiac test by their clients. The report of this survey will be of keen interest to insurers using (or contemplating the use of) NT-proBNP.
When life insurers set their underwriting requirement practices, the primary focus has always been on protective value (cost vs. benefit). In many smaller companies lacking the resources to conduct internal studies, the usual approach is to consider the practices of larger carriers and most notably those known to routinely do such studies.